Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Insurance Holdings (UVE) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Universal Insurance Holdings (UVE) over the last 16 years, with Q3 2025 value amounting to $405.1 million.

  • Universal Insurance Holdings' Cash & Equivalents rose 2140.87% to $405.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $405.1 million, marking a year-over-year increase of 2140.87%. This contributed to the annual value of $259.4 million for FY2024, which is 3470.0% down from last year.
  • According to the latest figures from Q3 2025, Universal Insurance Holdings' Cash & Equivalents is $405.1 million, which was up 2140.87% from $367.1 million recorded in Q2 2025.
  • In the past 5 years, Universal Insurance Holdings' Cash & Equivalents ranged from a high of $405.1 million in Q3 2025 and a low of $90.8 million during Q1 2021
  • For the 5-year period, Universal Insurance Holdings' Cash & Equivalents averaged around $307.2 million, with its median value being $317.0 million (2022).
  • As far as peak fluctuations go, Universal Insurance Holdings' Cash & Equivalents tumbled by 4975.72% in 2021, and later surged by 9961.24% in 2023.
  • Over the past 5 years, Universal Insurance Holdings' Cash & Equivalents (Quarter) stood at $250.5 million in 2021, then surged by 55.17% to $388.7 million in 2022, then rose by 2.21% to $397.3 million in 2023, then crashed by 34.7% to $259.4 million in 2024, then surged by 56.15% to $405.1 million in 2025.
  • Its Cash & Equivalents stands at $405.1 million for Q3 2025, versus $367.1 million for Q2 2025 and $398.2 million for Q1 2025.